stockrowHarrow, Inc. (HROW) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Harrow, Inc. HROW 26.05 −9.39%
- Ironwood Pharmaceuticals, Inc. IRWD 3.94 +4.51%
Harrow, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Harrow, Inc. is the larger, with a market value of $976.2M against $665.9M — 1.5× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.3×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 18.1%. Ironwood Pharmaceuticals, Inc. has the higher net margin (37.4% vs −13.5%) and the higher return on invested capital (0.00% vs −0.77%). Across the 19 metrics below, Ironwood Pharmaceuticals, Inc. leads on 15 and Harrow, Inc. on 4.
Valuation
Profitability
| Metric | HROW | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 73.28% | 100.00% | 53.51% |
| Operating margin | (1.00%) | 62.91% | 0.00% |
| Net margin | (13.51%) | 37.38% | (2.45%) |
| Free cash flow margin | (4.75%) | 51.31% | 0.00% |
| Return on equity | (116.07%) | (82.81%) | (0.80%) |
| Return on assets | (9.77%) | 43.58% | (1.67%) |
| Return on invested capital | (0.77%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack